On December 6, 2024 Alpha Tau Medical Ltd. ("Alpha Tau", or the "Company") (NASDAQ: DRTS, DRTSW), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT, reported that CFO Raphi Levy will present at the Ladenburg Oncology Innovators & Investors Symposium (Press release, Alpha Tau Medical, DEC 6, 2024, View Source [SID1234648851]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Event: Ladenburg Oncology Innovators & Investors Symposium
Format: Presentation and 1-on-1 Meetings
Date: December 12, 2024
Time: 11:00AM – 11:25AM EST
Location: Virtual

Please reach out to your Ladenburg representative to schedule 1-on-1 meetings with Mr. Levy.